Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Inhalte:

  • => Welche Forschungsthemen werden an der Medizinischen Universität bearbeitet?.
  • => Wer ist daran beteiligt und welche Methoden werden angewandt?.
  • => Welche Fördergeber unterstützen welche Projekte?.
  • => Wo werden Forschungsergebnisse publiziert?.

Facts and Figures: 2.627 Forscher*innenprofile (davon 1576 mit ORCID-ID), 8.421 Forschungsprojekte, 152.982 Publikationen, Posters und Vorträge, 63.242 Volltextlinks (davon Volltext frei zugänglich: > 27.660 (Open Access) )

Aktuelle Zitierungen im Web of Science: 1.929.505, davon 3.770 citation classics (>=100 Zitierungen) Summe Altmetrics Score: 289.238

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Metabolomics für Empagliflozin nach Myokardinfarkt
Projektleitung: von Lewinski Dirk
Laufzeit: 01.06.2025 - 31.05.2027
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

In vivo- Kompetition von AML-Zellen, die verschiedene TP53 -Aberrationen aufweisen
Projektleitung: Dutta Sayantanee
Laufzeit: 01.06.2025 - 01.06.2026
Geldgeber: Leukämiehilfe Steiermark

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):


13.05.2025:

Berger, N; Kramer, D; Schrempf, M; Hofer, E; Pichler, A; Fandler-Höfler, S; Haidegger, M; Hatab, I; Heine, M; Jagiello, J; Koller, H; Lilek, S; Veeranki, S; Enzinger, C; Gattringer, T; Kneihsl, M Predicting delirium in acute ischemic stroke: the PREDELIS score.
J Neurol. 2025; 272(6):391 Doi: 10.1007/s00415-025-13073-5
PubMed FullText FullText_MUG

 

12.05.2025:

Eglseer, D; Hristov, H; Krušič, S; Gregorič, N; Hren, I; Pravst, I; Lavriša, Ž Prevalence and Associated Factors of Sarcopenic Obesity Among Nursing Home Residents: A Cross-Sectional Multi-Centre Study.
J Cachexia Sarcopenia Muscle. 2025; 16(3):e13821 Doi: 10.1002/jcsm.13821 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

12.05.2025:

Grafakou, ME; Pferschy-Wenzig, EM; Aziz-Kalbhenn, H; Kelber, O; Moissl-Eichinger, C; Bauer, R Bidirectional interactions between St. John´s wort and gut microbiome: Potential implications on gut-brain-axis.
Biomed Pharmacother. 2025; 187:118111 Doi: 10.1016/j.biopha.2025.118111
PubMed FullText FullText_MUG

 

12.05.2025:

Bordag, N; Nagy, BM; Zügner, E; Ludwig, H; Foris, V; Nagaraj, C; Biasin, V; Kovacs, G; Kneidinger, N; Bodenhofer, U; Magnes, C; Maron, BA; Ulrich, S; Lange, TJ; Eichmann, TO; Hoetzenecker, K; Pieber, T; Olschewski, H; Olschewski, A Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025;
PubMed

 

12.05.2025:

Bereczki, D; Dénes, Á; Boneschi, FM; Akhvlediani, T; Cavallieri, F; Fanciulli, A; Filipović, SR; Guekht, A; Helbok, R; Hochmeister, S; von, Oertzen, TJ; Özturk, S; Priori, A; Rakusa, M; Willekens, B; Moro, E; Sellner, J, , NeuroCOVID-19, Task, Force, of, the, European, Academy, of, Neurology Need for awareness and surveillance of long-term post-COVID neurodegenerative disorders. A position paper from the neuroCOVID-19 task force of the European Academy of Neurology.
J Neurol. 2025; 272(6):380 Doi: 10.1007/s00415-025-13110-3 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

12.05.2025:

Reiter, BF; Bordag, N; Schnoegl, D; Delbeck, M; Madl, T; Habisch, H; Kwapiszewska, G; Meding, J; Marsh, LM The Acrolein - Lipopolysaccharide Mouse Model for Frequent Exacerbations in COPD.
Am J Respir Cell Mol Biol. 2025; Doi: 10.1165/rcmb.2024-0507MA
PubMed FullText FullText_MUG

 

12.05.2025:

Schumann, K; Klespe, KC; Mauch, C; Loquai, C; Schultheis, U; Börger, S; Thiem, A; Emmert, S; Hoellwerth, M; Koelbinger, P; Nguyen, VA; Wanner, M; Richtig, E; Peitsch, WK; Harth, W; Zenderowski, V; Braun, AD; Mengoni, M; Dummer, R; Mangana, J; Maul, LV; Meis, F; Rappersberger, K; Persa, OD; Biedermann, T; Posch, C Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.
J Eur Acad Dermatol Venereol. 2025; Doi: 10.1111/jdv.20708
PubMed FullText FullText_MUG

 

12.05.2025:

Oflaz, FE; Bondarenko, AI; Trenker, M; Waldeck-Weiermair, M; Gottschalk, B; Bernhart, E; Koshenov, Z; Radulović, S; Rost, R; Hirtl, M; Pilic, J; Karunanithi, Nivedita, A; Sagintayev, A; Leitinger, G; Brachvogel, B; Summerauer, S; Shoshan-Barmatz, V; Malli, R; Graier, WF Annexin A5 controls VDAC1-dependent mitochondrial Ca2+ homeostasis and determines cellular susceptibility to apoptosis.
EMBO J. 2025; Doi: 10.1038/s44318-025-00454-9
PubMed FullText FullText_MUG

 

12.05.2025:

Föderl-Höbenreich, E; Panzitt, K Ex vivo culture models to study viral infections of the liver.
Curr Opin Virol. 2025; 71:101462 Doi: 10.1016/j.coviro.2025.101462
PubMed FullText FullText_MUG

 

12.05.2025:

Hammer, S; Eichlseder, M; Klivinyi, C; Lang-Illievich, K; Moser, A; Pichler, A; Schreiber, N; Zoidl, P; Bornemann-Cimenti, H Effects of departmental green anaesthesia interventions on carbon dioxide equivalent emissions: a systematic review.
Br J Anaesth. 2025; Doi: 10.1016/j.bja.2025.03.038
PubMed FullText FullText_MUG

 

12.05.2025:

Laudańska, Z; Caunt, A; Cristia, A; Warlaumont, A; Patsis, K; Tomalski, P; Warreyn, P; Abney, DH; Borjon, JI; Airaksinen, M; Jones, EJ; Bölte, S; Dall, M; Holzinger, D; Poustka, L; Roeyers, H; Wass, S; Zhang, D; Marschik, PB From data to discovery: Technology propels speech-language research and theory-building in developmental science.
Neurosci Biobehav Rev. 2025; 174:106199 Doi: 10.1016/j.neubiorev.2025.106199
PubMed FullText FullText_MUG

 

08.05.2025:

Van, Santvliet, L; Zappon, E; Gsell, MAF; Thaler, F; Blondeel, M; Dymarkowski, S; Claessen, G; Willems, R; Urschler, M; Vandenberk, B; Plank, G; De, Vos, M Integrating anatomy and electrophysiology in the healthy human heart: Insights from biventricular statistical shape analysis using universal coordinates.
Comput Biol Med. 2025; 192(Pt A):110230 Doi: 10.1016/j.compbiomed.2025.110230
PubMed FullText FullText_MUG

 

07.05.2025:

Yaldizli, Ö; Benkert, P; Achtnichts, L; Bar-Or, A; Bohner-Lang, V; Bridel, C; Comabella, M; Findling, O; Disanto, G; Finkener, S; Gobbi, C; Granziera, C; Herwerth, M; Hoepner, R; Horakova, D; Kamber, N; Khalil, M; Kunz, P; Lalive, P; Linker, R; Lorscheider, J; Müller, S; Oechtering, J; Pettypool, V; Piehl, F; Pot, C; Roth, P; Théaudin, M; Tintore, M; Tur, C; Uffer, D; Uginet, M; Vehoff, J; Wiendl, H; Ziemssen, T; Zecca, C; Salmen, A; Leppert, D; Derfuss, T; Kappos, L; Hemkens, LG; Janiaud, P; Kuhle, J Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.
Mult Scler. 2025; 13524585251335466 Doi: 10.1177/13524585251335466
Web of Science PubMed FullText FullText_MUG

 

07.05.2025:

Exl, MT; Fischbacher, S; Lindroth, H; Liu, K; Hoffmann, M; Jeitziner, MM; Nydahl, P; von, Haken, R; Krüger, L; Schimböck, F, , WDAD, Study, Group Delirium prevalence, interventions and barriers in intensive care units in German-speaking countries: A retrospective cross-sectional secondary analysis.
Nurs Crit Care. 2025; 30(3): e70041 Doi: 10.1111/nicc.70041
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)


Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.


Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).


JIFnorm: Proportional Distribution


Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.


JIFnorm: Absolut Impact


1 This analysis considered only publications categorized as full papers/original articles.

2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.

© Med Uni Graz Impressum